Targeting neurotrophin-3 and its dependence receptor tyrosine kinase receptor C: a new antitumoral strategy

被引:14
作者
Tauszig-Delamasure, Servane [1 ]
Bouzas-Rodriguez, Jimena [1 ]
机构
[1] Univ Lyon, Ctr Leon Berard, CNRS,Ctr Cancerol Lyon,INSERM,U1052,UMR5238, Apoptosis Canc & Dev Lab,Equipe Labellisee La Lig, F-69008 Lyon, France
关键词
apoptosis; dependence receptor; neuroblastoma; neurotrophin; NT-3; TrkC; NERVE GROWTH-FACTOR; PHASE-I TRIAL; CASPASE CLEAVAGE; HUMAN NEUROBLASTOMAS; MESSENGER-RNAS; HUMAN MEDULLOBLASTOMA; SURVIVAL FACTOR; CELL INVASION; NETRIN-1; ACTS; FACTOR FAMILY;
D O I
10.1517/14728222.2011.575361
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Areas covered: The role of neurotrophin-3 (NT-3) and its dependence receptor TrkC in neuroblastoma, and its suitability as a therapeutic target. Expert opinion: Autocrine production of NT-3 represents a selective advantage for tumor growth and dissemination, in a large fraction of aggressive neuroblastoma. Disruption of the NT-3 autocrine loop in malignant neuroblasts, triggers neuroblastoma cell death, and inhibits neuroblastoma metastasis in animal models. Thus, a novel way of targeting the tyrosine kinase receptor, is via the reactivation of its intrinsic ability to trigger cell death.
引用
收藏
页码:847 / 858
页数:12
相关论文
共 63 条
[1]   NEUROTROPHIC FACTORS AND THEIR RECEPTORS [J].
BARBACID, M .
CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (02) :148-155
[2]   PURIFICATION OF A NEW NEUROTROPHIC FACTOR FROM MAMMALIAN BRAIN [J].
BARDE, YA ;
EDGAR, D ;
THOENEN, H .
EMBO JOURNAL, 1982, 1 (05) :549-553
[3]   Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system [J].
Bibel, M ;
Barde, YA .
GENES & DEVELOPMENT, 2000, 14 (23) :2919-2937
[4]   The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease [J].
Bordeaux, MC ;
Forcet, C ;
Granger, L ;
Corset, V ;
Bidaud, C ;
Billaud, M ;
Bredesen, DE ;
Edery, P ;
Mehlen, P .
EMBO JOURNAL, 2000, 19 (15) :4056-4063
[5]   Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis [J].
Bouzas-Rodriguez, Jimena ;
Cabrera, Jorge Ruben ;
Delloye-Bourgeois, Celine ;
Ichim, Gabriel ;
Delcros, Jean-Guy ;
Raquin, Marie-Anne ;
Rousseau, Raphael ;
Combaret, Valerie ;
Benard, Jean ;
Tauszig-Delamasure, Servane ;
Mehlen, Patrick .
JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (03) :850-858
[6]   Receptors that mediate cellular dependence [J].
Bredesen, DE ;
Mehlen, P ;
Rabizadeh, S .
CELL DEATH AND DIFFERENTIATION, 2005, 12 (08) :1031-1043
[7]   Trk Receptor Expression and Inhibition in Neuroblastomas [J].
Brodeur, Garrett M. ;
Minturn, Jane E. ;
Ho, Ruth ;
Simpson, Anisha M. ;
Iyer, Radhika ;
Varela, Carly R. ;
Light, Jennifer E. ;
Kolla, Venkatadri ;
Evans, Audrey E. .
CLINICAL CANCER RESEARCH, 2009, 15 (10) :3244-3250
[8]   Expression of TrkA, TrkB and TrkC in human neuroblastomas [J].
Brodeur, GM ;
Nakagawara, A ;
Yamashiro, DJ ;
Ikegaki, N ;
Liu, XG ;
Azar, CG ;
Lee, CP ;
Evans, AE .
JOURNAL OF NEURO-ONCOLOGY, 1997, 31 (1-2) :49-55
[9]   The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth [J].
Canibano, Carmen ;
Rodriguez, Noela L. ;
Saez, Carmen ;
Tovar, Sulay ;
Garcia-Lavandeira, Montse ;
Grazia Borrello, Maria ;
Vidal, Anxo ;
Costantini, Frank ;
Japon, Miguel ;
Dieguez, Carlos ;
Alvarez, Clara V. .
EMBO JOURNAL, 2007, 26 (08) :2015-2028
[10]   A phase I trial of CEP-701+gemcitabine in patients with advanced adenocarcinoma of the pancreas [J].
Chan, Emily ;
Mulkerin, Daniel ;
Rothenberg, Mace ;
Holen, Kyle D. ;
Lockhart, A. Craig ;
Thomas, James ;
Berlin, Jordan .
INVESTIGATIONAL NEW DRUGS, 2008, 26 (03) :241-247